Comerica Bank
CERE

Comerica Bank’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Comerica Bank’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-378
Closed -$15.4K – 3804
2024
Q2 		$15.4K Sell
378
-365
-49% -$15.2K ﹤0.01% 3061
2024
Q1 		$31.4K Sell
743
-69,207
-99% -$2.91M ﹤0.01% 2901
2023
Q4 		$2.97M Buy
+69,950
New +$2.01M 0.01% 964

Other funds holding CERE

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Comerica Bank's CERE Position: Q3 2024 in Review

Comerica Bank sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 378 shares — an estimated $15.4K sold.

Comerica Bank first reported a position in CERE in Q4 2023 and held it in 3 quarters. The position peaked at $2.97M in Q4 2023. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

  • Comerica Bank reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Comerica Bank sold 378 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $15.4K.
  • Comerica Bank first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q4 2023 and held it in 3 quarters.
  • Comerica Bank's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $2.97M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on Comerica Bank's 13F filing for Q3 2024, filed 14 Nov 2024.